BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19211271)

  • 1. Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation.
    Bukowska A; Röcken C; Erxleben M; Röhl FW; Hammwöhner M; Huth C; Ebert MP; Lendeckel U; Goette A
    Cardiovasc Pathol; 2010; 19(3):e51-60. PubMed ID: 19211271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation.
    Han W; Fu S; Wei N; Xie B; Li W; Yang S; Li Y; Liang Z; Huo H
    Int J Cardiol; 2008 Nov; 130(2):165-73. PubMed ID: 18585800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats.
    Yamashita T; Sekiguchi A; Kato T; Tsuneda T; Iwasaki YK; Sagara K; Iinuma H; Sawada H; Aizawa T
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):127-32. PubMed ID: 17907100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The experimental study on changes of endothelial nitric oxide synthase and plasminogen activator inhibitor-1 protein in the canine atrial fibrillation model].
    Han W; Li WM; Song LY; Li Y; Yang SS; Huang YL; Gan RT; Kou JJ; Geng JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):69-72. PubMed ID: 15924787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of NOS-1 in the sarcolemma region of a subpopulation of atrial cardiomyocytes including myoendocrine cells and NOS-3 in vascular and endocardial endothelial cells of the rat heart.
    Miethke A; Feussner M; Planitzer G; Richter H; Gutsmann M; Gossrau R
    Acta Histochem; 2003; 105(1):43-55. PubMed ID: 12666987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.
    Goldsmith I; Kumar P; Carter P; Blann AD; Patel RL; Lip GY
    Am Heart J; 2000 Nov; 140(5):777-84. PubMed ID: 11054625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria.
    Yamashita T; Sekiguchi A; Iwasaki YK; Sagara K; Hatano S; Iinuma H; Aizawa T; Fu LT
    Circulation; 2003 Nov; 108(20):2450-2. PubMed ID: 14610015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.
    Kim YM; Guzik TJ; Zhang YH; Zhang MH; Kattach H; Ratnatunga C; Pillai R; Channon KM; Casadei B
    Circ Res; 2005 Sep; 97(7):629-36. PubMed ID: 16123335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation.
    Boldt A; Scholl A; Garbade J; Resetar ME; Mohr FW; Gummert JF; Dhein S
    Basic Res Cardiol; 2006 May; 101(3):261-7. PubMed ID: 16382287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
    Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.
    Akar JG; Jeske W; Wilber DJ
    J Am Coll Cardiol; 2008 May; 51(18):1790-3. PubMed ID: 18452786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
    Tsai CT; Chiang FT; Tseng CD; Hwang JJ; Kuo KT; Wu CK; Yu CC; Wang YC; Lai LP; Lin JL
    J Am Coll Cardiol; 2010 Feb; 55(8):758-70. PubMed ID: 20170814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.
    Morawietz H; Rohrbach S; Rueckschloss U; Schellenberger E; Hakim K; Zerkowski HR; Kojda G; Darmer D; Holtz J
    Eur J Clin Invest; 2006 Oct; 36(10):705-12. PubMed ID: 16968466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression.
    Danson EJ; Zhang YH; Sears CE; Edwards AR; Casadei B; Paterson DJ
    Cardiovasc Res; 2005 Sep; 67(4):613-23. PubMed ID: 15936740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Up-regulation of inositol 1, 4, 5-trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation].
    Yamada J; Ohkusa T; Nao T; Ueyama T; Yano M; Kobayashi S; Hamano K; Esato K; Matsuzaki M
    J Cardiol; 2002 Jan; 39(1):57-8. PubMed ID: 11828801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of histamine on endothelial nitric oxide synthase expression in pulmonary artery endothelial cells].
    Lu DQ; Li HG; Ye H; Ye SQ; Jin S; Wang DX
    Sheng Li Xue Bao; 2004 Jun; 56(3):288-94. PubMed ID: 15224139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.